145 related articles for article (PubMed ID: 7957975)
1. Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
Ciotta L; Cianci A; Marletta E; Pisana L; Aglianò A; Palumbo G
Fertil Steril; 1994 Dec; 62(6):1129-35. PubMed ID: 7957975
[TBL] [Abstract][Full Text] [Related]
2. Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease.
Ciotta L; Cianci A; Giuffrida G; Marletta E; Aglianò A; Palumbo G
Fertil Steril; 1996 Jan; 65(1):61-7. PubMed ID: 8557156
[TBL] [Abstract][Full Text] [Related]
3. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
De Leo V; Fulghesu AM; la Marca A; Morgante G; Pasqui L; Talluri B; Torricelli M; Caruso A
Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism.
Dodin S; Faure N; Cédrin I; Méchain C; Turcot-Lemay L; Guy J; Lemay A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):575-82. PubMed ID: 8548942
[TBL] [Abstract][Full Text] [Related]
5. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
Bahceci M; Bilge M; Tuzcu A; Tuzcu S; Bahceci S
J Endocrinol Invest; 2004 Apr; 27(4):353-6. PubMed ID: 15233555
[TBL] [Abstract][Full Text] [Related]
6. Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms.
Acién P; Mauri M; Gutierrez M
Hum Reprod; 1997 Mar; 12(3):423-9. PubMed ID: 9130733
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
Fruzzetti F; Bersi C; Parrini D; Ricci C; Genazzani AR
Fertil Steril; 1999 Mar; 71(3):445-51. PubMed ID: 10065780
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: effects on hair, bone, and hormone profile after 1-year use.
Castelo-Branco C; Martínez de Osaba MJ; Pons F; Fortuny A
Metabolism; 1997 Apr; 46(4):437-40. PubMed ID: 9109850
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hirsutism in women with flutamide.
Marcondes JA; Minnani SL; Luthold WW; Wajchenberg BL; Samojlik E; Kirschner MA
Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of flutamide alone or combined with oral contraceptives in the treatment of hirsutism in women].
Devoto E; Aravena L
Rev Med Chil; 2004 Jul; 132(7):845-52. PubMed ID: 15379332
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
Falsetti L; De Fusco D; Eleftheriou G; Rosina B
Gynecol Endocrinol; 1997 Aug; 11(4):251-7. PubMed ID: 9272421
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism.
Taner C; Inal M; Başogul O; Onoglu A; Karanfil C; Tinar S; Ispahi C
Gynecol Obstet Invest; 2002; 54(2):105-8. PubMed ID: 12566753
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism.
Breitkopf DM; Rosen MP; Young SL; Nagamani M
Contraception; 2003 May; 67(5):349-53. PubMed ID: 12742556
[TBL] [Abstract][Full Text] [Related]
16. The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism.
Dikensoy E; Balat O; Pence S; Akcali C; Cicek H
Arch Gynecol Obstet; 2009 Mar; 279(3):321-7. PubMed ID: 18607612
[TBL] [Abstract][Full Text] [Related]
17. Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome.
Pucci E; Genazzani AD; Monzani F; Lippi F; Angelini F; Gargani M; Barletta D; Luisi M; Genazzani AR
Gynecol Endocrinol; 1995 Sep; 9(3):221-8. PubMed ID: 8540292
[TBL] [Abstract][Full Text] [Related]
18. The effect of an oral contraceptive containing ethinylestradiol and desogestrel on hair growth and hormonal parameters of hirsute women.
Ruutiainen K
Int J Gynaecol Obstet; 1986 Oct; 24(5):361-8. PubMed ID: 2880770
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism.
Müderris II; Bayram F; Güven M
Fertil Steril; 2000 May; 73(5):984-7. PubMed ID: 10785225
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism.
Müderris II; Bayram F; Sahin Y; Keleştimur F; Tutuş A; Ayata D
Fertil Steril; 1996 Aug; 66(2):220-2. PubMed ID: 8690105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
